Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia

Completed · Phase 1/Phase 2

Conditions studied: Fibromyalgia

In brief

The purpose of this study is to determine if intravenous micronutrient therapy (IVMT) is effective in the treatment of fibromyalgia, as assessed by validated functional and pain measures.

Key facts

Study ID

NCT00067405

Run by

National Center for Complementary and Integrative Health (NCCIH)

People needed

40

Starts

2004-06-01

Expected to finish

2007-07-01

Last updated by the study team

2008-04-22

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meet the American College of Rheumatology criteria for Fibromyalgia diagnosis;
• On no medication for Fibromyalgia other than acetaminophen, or willing to stop all such medication for the duration of the study
• Willing to stop all FMS medication for the duration of the study or be on a stable dose of such medication for at least 3 months

You may not qualify if…

• Other concurrent medical conditions such as rheumatologic disease, chronic infection, untreated endocrine disorders, unstable seizures, psychiatric disorders, acute peptic ulcer disease, congestive heart failure, chronic liver disorders and/or bleeding problems
• Allergy to thiamin
• Unwilling to stop vitamin supplementation for the duration of the study
• PLEASE NOTE: Travel to and accomodations at the study site can NOT be compensated. Anyone wishing to travel from outside of the study site's geographic area must do so at their own risk and expense.

Where it is running

• Yale-Griffin Prevention Research Center — Derby, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.